Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126129001 | 12612900 | 1 | I | 20160530 | 20160719 | 20160802 | 20160802 | EXP | GB-CIPLA LTD.-2016GB10091 | CIPLA | 0.00 | Y | 0.00000 | 20160802 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126129001 | 12612900 | 1 | PS | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG | QD | |||||
| 126129001 | 12612900 | 2 | SS | Gliclazide | GLICLAZIDE | 1 | Unknown | 80 MG, QD | U | U | 0 | 80 | MG | QD | |||||
| 126129001 | 12612900 | 3 | SS | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | Unknown | 500 MG, QD | U | U | 0 | 500 | MG | QD | |||||
| 126129001 | 12612900 | 4 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 30 MG, QD | U | U | 0 | 30 | MG | QD | |||||
| 126129001 | 12612900 | 5 | SS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126129001 | 12612900 | 6 | SS | Paracetamol | ACETAMINOPHEN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126129001 | 12612900 | 7 | SS | Salbutamol | ALBUTEROL | 1 | Unknown | 5 MG, QD | U | U | 0 | 5 | MG | QD | |||||
| 126129001 | 12612900 | 8 | SS | Tamsulosin | TAMSULOSIN | 1 | Unknown | 400 MG, QD | U | U | 0 | 400 | MG | QD | |||||
| 126129001 | 12612900 | 9 | SS | Tiotropium | TIOTROPIUM | 1 | Unknown | 18 UNK, QD | U | U | 0 | QD | |||||||
| 126129001 | 12612900 | 10 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | 75 MG, QD | U | U | 0 | 75 | MG | QD | |||||
| 126129001 | 12612900 | 11 | SS | Carbocisteine | CARBOCYSTEINE | 1 | Unknown | 750 MG, QD | U | U | 0 | 750 | MG | QD | |||||
| 126129001 | 12612900 | 12 | SS | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 180 MG, QD | U | U | 0 | 180 | MG | QD | |||||
| 126129001 | 12612900 | 13 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126129001 | 12612900 | 14 | SS | Fostair | BECLOMETHASONEFORMOTEROL | 1 | Unknown | 2 DF, BID | U | U | 0 | 2 | DF | BID | |||||
| 126129001 | 12612900 | 15 | SS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Unknown | 200 MG, QD | U | U | 0 | 200 | MG | QD | |||||
| 126129001 | 12612900 | 16 | SS | Linagliptin | LINAGLIPTIN | 1 | Unknown | 5 MG, QD | U | U | 0 | 5 | MG | QD | |||||
| 126129001 | 12612900 | 17 | SS | Tazocin | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 G, QD | 0 | 13.5 | G | QD | |||||||
| 126129001 | 12612900 | 18 | SS | Tazocin | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 G, QD | 0 | 13.5 | G | QD | |||||||
| 126129001 | 12612900 | 19 | SS | Tazocin | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 13.5 G, QD | 0 | 13.5 | G | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126129001 | 12612900 | 2 | Product used for unknown indication |
| 126129001 | 12612900 | 3 | Product used for unknown indication |
| 126129001 | 12612900 | 4 | Product used for unknown indication |
| 126129001 | 12612900 | 5 | Product used for unknown indication |
| 126129001 | 12612900 | 6 | Product used for unknown indication |
| 126129001 | 12612900 | 7 | Product used for unknown indication |
| 126129001 | 12612900 | 8 | Product used for unknown indication |
| 126129001 | 12612900 | 9 | Product used for unknown indication |
| 126129001 | 12612900 | 10 | Product used for unknown indication |
| 126129001 | 12612900 | 11 | Product used for unknown indication |
| 126129001 | 12612900 | 12 | Product used for unknown indication |
| 126129001 | 12612900 | 13 | Product used for unknown indication |
| 126129001 | 12612900 | 14 | Product used for unknown indication |
| 126129001 | 12612900 | 15 | Product used for unknown indication |
| 126129001 | 12612900 | 16 | Product used for unknown indication |
| 126129001 | 12612900 | 17 | Respiratory failure |
| 126129001 | 12612900 | 18 | Chronic obstructive pulmonary disease |
| 126129001 | 12612900 | 19 | Lower respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126129001 | 12612900 | DE |
| 126129001 | 12612900 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126129001 | 12612900 | Condition aggravated | |
| 126129001 | 12612900 | Dyspnoea | |
| 126129001 | 12612900 | Oxygen saturation decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |